Cases & Deals

Cougar Biotechnology builds global patent portfolio for prostate cancer treatment

Clients Cougar Biotechnology, Inc.

On behalf of Cougar Biotechnology, Inc. Jones Day assisted with the development of its global patent portfolio related to the use of 17 alpha-hydroxylase/C17,20-lyase inhibitors to treat cancer.